Eyes on the future

Oxford BioMedica annual report 2011

thinkerdoer designed the Oxford BioMedica 2011 annual report with the focus on showcasing their ocular product treatments which have the potential of a single administration to provide long-term therapeutic benefit. OXB's LentiVector® platform products could significantly reduce the social care burden associated with neuro-degenerative or ocular diseases.

annual reports